Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gumix International is a leading importer, processor, and supplier of water-soluble gums and hydrocolloids for the pharmaceutical, food, and cosmetic industries. Founded in 1947, the company specializes in natural resins such as Gum Arabic, Gum Tragacanth, and Gum Karaya, providing high-quality excipients used in drug formulation and delivery systems. Their products serve as stabilizers, emulsifiers, and thickening agents in various healthcare applications. The company operates processing facilities that ensure products meet stringent USP/NF and other international pharmacopeia standards. Gumix serves a global market from its headquarters in New Jersey, maintaining a long-standing reputation for technical support and raw material reliability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gumix International.